Analysts remain skeptical about DocGo's long-term valuation ...

Analysts remain skeptical about DocGo's long-term valuation despite upgrades to earnings and revenue estimates. Expectations still predict a slowdown of the company's revenue growth, albeit still outpacing the wider industry.